Cipla Ltd.

Credit rating agency, CARE has reaffirmed ‘AAA’ rating to Cipla’s long term fund based bank facilities worth RS 60.09 crore. The rating agency has assigned ‘AAA’ rating to short term fund based bank facilities of the bank, while reaffirmed ‘A1+’ rating to the bank’s short term non fund based bank facilities worth Rs 58.41 crore.

The reaffirmation of ratings assigned to bank facilities of Cipla derives strength from its reputed brand having global presence, well established and experienced promoters, dominant market position in domestic pharmaceutical industry, robust operational performance and strong financial risk profile.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 170 countries. Its portfolio includes 2000 products in 65 therapeutic categories with one quality standard globally.